Site icon pharmaceutical daily

Ablynx prices $200M public offering, trades on NASDAQ

Ablynx

Ablynx

Belgian Ablynx on Wednesday announced the pricing of its initial U.S. public offering totaling $200 million, from 11,430,000 American Depositary Shares (“ADSs”) at a price of $17.50 per ADS.

The ADSs are expected to begin trading on the NASDAQ Global Select Market on October 25, 2017.

Ablynx has granted the underwriters during the 30-day stabilization period an option to purchase up to
an additional 1,714,500 ordinary shares in the form of ADSs in connection with the offering, representing
up to 15% of the total number of ADSs placed in the offering.

The closing company expects the offering to close on October 27, 2017.

Exit mobile version